Answer
Yes, ifosfamide carries a risk of secondary tumours and their precursors, potentially developing years after chemotherapy ends, and increases the risk of myelodysplastic changes, some progressing to acute leukaemias.
Sources for this answer
- Ifosfamide Injection 1gBaxter Healthcare Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked